Treatment of obstructive sleep apnea improves blood pressure in men

A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.

"All types of patients may benefit from this treatment, even those with other ," said Bharati Prasad, MD, MS, the study's principal investigator. "It's important to now do a prospective study enrolling different types of patients with sleep apnea."

The study, appearing in the Oct. 15 issue of the Journal of Clinical , examined the effectiveness of obstructive sleep apnea treatment on and diabetes control in 221 men with preexisting hypertension or type 2 diabetes and a new diagnosis of OSA. Participants received positive airway pressure (PAP) therapy upon treatment initiation.

Results show that both systolic and diastolic blood pressure decreased significantly with initiation of OSA treatment at both the first follow-up, 3-6 months after initiation, and the second follow-up, 9-12 months later.

According to the authors, this is the first study to examine the effectiveness of treatment of obstructive sleep apnea on routine measures of hypertension and in a practice-based clinical setting. The results show the real-world effectiveness of OSA treatment on hypertension.

More information: "Effects of Positive Airway Pressure Treatment on Clinical Measures of Hypertension and Type 2 Diabetes," Journal of Clinical Sleep Medicine, 2012.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Osteoporosis risk heightened among sleep apnea patients

Apr 15, 2014

A diagnosis of obstructive sleep apnea may raise the risk of osteoporosis, particularly among women or older individuals, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & ...

Sleep apnea linked with blood sugar levels

Apr 02, 2014

Sleep apnoea has been linked with elevated blood sugar levels, suggesting people with the condition could be at an increased risk of cardiovascular illness and mortality.

User comments